Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
0 competitors in Neovascular (Wet) Age-Related Macular Degeneration
View Full LandscapeTarget Indication
Neovascular (Wet) Age-Related Macular Degeneration
Clinical Trial
NCT05197270Last updated: 8/17/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Macular Neovascularization Secondary to Age-Related Macular Degeneration
COVID-19
Multiple Myeloma in Relapse
Large Cell Neuroendocrine Carcinoma
Leukemia